From the "About PharmAust" section at the bottom of the announcement :
"The Neurodegenerative Disease Market size is estimated at USD 55.12 billion in 2024, and is expected to reach USD 77.82 billion by 2029, growing at a CAGR of 7.14% during the forecast period (2024-2029)²."
Ongoing successful outcomes for MPL in the Neuro Disease space may bring to mind the 1974-75 winner of Melbourne Cup - THINK BIG !!
Ann: PharmAust makes Head of Manufacturing appointment, page-20
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.010(5.41%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 17.5¢ | $58.74K | 325.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 270003 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 116651 | 3 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
-0.010 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 18.0¢ | 18.0¢ | 17.5¢ | 141605 | ||
| Last updated 15.28pm 21/05/2024 ? | |||||
| PAA (ASX) Chart |